Ray Dalio's MDGL Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 53,627 shares of Madrigal Pharmaceuticals, Inc. (MDGL) worth $27.03 M, representing 0.12% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Ray Dalio has maintained this position in MDGL for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 53,627 shares. Largest reduction occurred in Q1 2026, reducing 15,298 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Madrigal Pharmaceuticals (MDGL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Madrigal Pharmaceuticals (MDGL) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +53,627 | New Buy | 53,627 | $503.96 |
| Q2 2026 | -3,920 | Sold Out | 0 | $0.00 |
| Q1 2026 | -15,298 | Reduce 79.60% | 3,920 | $523.47 |
| Q4 2025 | -8,567 | Reduce 30.83% | 19,218 | $582.34 |
| Q3 2025 | +27,785 | New Buy | 27,785 | $458.66 |
Ray Dalio's Madrigal Pharmaceuticals Investment FAQs
Ray Dalio first purchased Madrigal Pharmaceuticals, Inc. (MDGL) in Q3 2025, acquiring 27,785 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Madrigal Pharmaceuticals, Inc. (MDGL) for 5 quarters since Q3 2025.
Ray Dalio's largest addition to Madrigal Pharmaceuticals, Inc. (MDGL) was in Q3 2026, adding 53,627 shares worth $27.03 M.
According to the latest 13F filing for Q3 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 53,627 shares of Madrigal Pharmaceuticals, Inc. (MDGL), valued at approximately $27.03 M.
As of the Q3 2026 filing, Madrigal Pharmaceuticals, Inc. (MDGL) represents approximately 0.12% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Madrigal Pharmaceuticals, Inc. (MDGL) was 53,627 shares, as reported at the end of Q3 2026.